Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia 4Melanoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Gliosarcoma 2Glioblastoma 2Congenital Abnormalities 2Central Nervous System Neoplasms 2Brain Neoplasms 2Astrocytoma 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Plasma Cell 1Metastatic Solid Tumors 1Meningioma 1Medulloblastoma 1Lymphoma, Follicular 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Glioma, Subependymal 1Glioma 1Familial ependymoma 1Fallopian Tube Neoplasms 1Ependymoma 1

Interventions

Iodine-125 1FANG vaccine 1Cell- and Tissue-Based Therapy 1Antibodies, Bispecific 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Metastatic Solid Tumors × FANG vaccine × Clear all
NCT00148993 2011-04-08

Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors

Hadassah Medical Organization

Phase 1/2 Withdrawn
100 enrolled
Other solid neoplasm

Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡